221 related articles for article (PubMed ID: 30094591)
1. Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review.
Pike J; Grosse SD
Appl Health Econ Health Policy; 2018 Dec; 16(6):765-778. PubMed ID: 30094591
[TBL] [Abstract][Full Text] [Related]
2. Cancer Premature Mortality Costs in Europe in 2020: A Comparison of the Human Capital Approach and the Friction Cost Approach.
Hanly P; Ortega-Ortega M; Soerjomataram I
Curr Oncol; 2022 May; 29(5):3552-3564. PubMed ID: 35621677
[TBL] [Abstract][Full Text] [Related]
3. Advances in the methodological approach to friction period estimation: A European perspective.
Hanly P; Ortega Ortega M; Pearce A; Soerjomataram I; Sharp L
Soc Sci Med; 2020 Nov; 264():113289. PubMed ID: 32836019
[TBL] [Abstract][Full Text] [Related]
4. Estimating Global Friction Periods for Economic Evaluation: A Case Study of Selected OECD Member Countries.
Hanly P; Ortega Ortega M; Pearce A; de Camargo Cancela M; Soerjomataram I; Sharp L
Pharmacoeconomics; 2023 Sep; 41(9):1093-1101. PubMed ID: 37036642
[TBL] [Abstract][Full Text] [Related]
5. Component costs of foodborne illness: a scoping review.
McLinden T; Sargeant JM; Thomas MK; Papadopoulos A; Fazil A
BMC Public Health; 2014 May; 14():509. PubMed ID: 24885154
[TBL] [Abstract][Full Text] [Related]
6. Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018.
Ortega-Ortega M; Hanly P; Pearce A; Soerjomataram I; Sharp L
Int J Cancer; 2022 Feb; 150(4):580-593. PubMed ID: 34569617
[TBL] [Abstract][Full Text] [Related]
7. Productivity costs from a dengue episode in Asia: a systematic literature review.
Hung TM; Shepard DS; Bettis AA; Nguyen HA; McBride A; Clapham HE; Turner HC
BMC Infect Dis; 2020 Jun; 20(1):393. PubMed ID: 32493234
[TBL] [Abstract][Full Text] [Related]
8. Indirect Costs Due to Lung Cancer-Related Premature Mortality in Four European Countries.
Bencina G; Chami N; Hughes R; Weston G; Baxter C; Salomonsson S; Demedts I
Adv Ther; 2023 Jul; 40(7):3056-3069. PubMed ID: 37195488
[TBL] [Abstract][Full Text] [Related]
9. Cost of Illness of Multiple Sclerosis - A Systematic Review.
Ernstsson O; Gyllensten H; Alexanderson K; Tinghög P; Friberg E; Norlund A
PLoS One; 2016; 11(7):e0159129. PubMed ID: 27411042
[TBL] [Abstract][Full Text] [Related]
10. Productivity costs of schizophrenia spectrum and other psychotic disorders by friction cost and human capital methods: The Northern Finland Birth Cohort 1966.
Majuri T; Nerg I; Huikari S; Rissanen I; Jääskeläinen E; Miettunen J; Korhonen M
Soc Psychiatry Psychiatr Epidemiol; 2024 Mar; ():. PubMed ID: 38517515
[TBL] [Abstract][Full Text] [Related]
11. A prospective health economic evaluation to determine the productivity loss due to premature mortality from oral cancer in India.
Singh A; Sullivan R; Bavaskar M; Shetty R; Joshi P; Nair S; Gupta S; Chaturvedi P; Badwe R
Head Neck; 2024 Jun; 46(6):1263-1269. PubMed ID: 38622958
[TBL] [Abstract][Full Text] [Related]
12. Productivity losses associated with premature mortality due to cancer in Russia: A population-wide study covering 2001-2030.
Barchuk A; Bespalov A; Huhtala H; Chimed T; Belyaev A; Moore M; Anttila A; Auvinen A; Pearce A; Soerjomataram I
Scand J Public Health; 2019 Jul; 47(5):482-491. PubMed ID: 31313982
[No Abstract] [Full Text] [Related]
13. A systemmatic literature review on indirect costs of women with breast cancer.
Mohammadpour S; Soleimanpour S; Javan-Noughabi J; Gallehzan NA; Aboutorabi A; Jahangiri R; Bagherzadeh R; Gorman JF; Nemati A
Cost Eff Resour Alloc; 2022 Dec; 20(1):68. PubMed ID: 36510211
[TBL] [Abstract][Full Text] [Related]
14. The Economic Burden of Biological Drugs in Rheumatoid Arthritis Treatment.
Grega D; Kolář J
Value Health Reg Issues; 2024 Mar; 40():13-18. PubMed ID: 37972429
[TBL] [Abstract][Full Text] [Related]
15. Methodological considerations in cost of illness studies on Alzheimer disease.
Costa N; Derumeaux H; Rapp T; Garnault V; Ferlicoq L; Gillette S; Andrieu S; Vellas B; Lamure M; Grand A; Molinier L
Health Econ Rev; 2012 Sep; 2(1):18. PubMed ID: 22963680
[TBL] [Abstract][Full Text] [Related]
16. Productivity costs of lifelong smoking-the Northern Finland Birth Cohort 1966 study.
Rissanen I; Nerg I; Oura P; Huikari S; Korhonen M
Eur J Public Health; 2024 Mar; ():. PubMed ID: 38552215
[TBL] [Abstract][Full Text] [Related]
17. The Indirect Cost Burden of Cancer Care in Canada: A Systematic Literature Review.
Iragorri N; de Oliveira C; Fitzgerald N; Essue B
Appl Health Econ Health Policy; 2021 May; 19(3):325-341. PubMed ID: 33368032
[TBL] [Abstract][Full Text] [Related]
18. Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands-a Holistic Approach.
Zeevat F; Simons JJM; Westra TA; Wilschut JC; van Sorge NM; Boersma C; Postma MJ
Infect Dis Ther; 2024 Mar; 13(3):481-499. PubMed ID: 38366286
[TBL] [Abstract][Full Text] [Related]
19. Estimating the Incidence and Economic Cost of Lyme Disease Cases in Canada in the 21st Century with Projected Climate Change.
Ogden NH; Dumas A; Gachon P; Rafferty E
Environ Health Perspect; 2024 Feb; 132(2):27005. PubMed ID: 38349724
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
